IMC Chicago’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$104K Sell
36,250
-41,654
-53% -$106K ﹤0.01% 5970
2026
Q1
$153K Sell
77,904
-46,254
-37% -$109K ﹤0.01% 5162
2025
Q4
$336K Buy
124,158
+46,791
+60% +$154K ﹤0.01% 3731
2025
Q3
$327K Sell
77,367
-1,249
-2% -$5.49K ﹤0.01% 3378
2025
Q2
$392K Buy
78,616
+13,330
+20% +$57.9K ﹤0.01% 2990
2025
Q1
$288K Sell
65,286
-29
-0% -$136 ﹤0.01% 2944
2024
Q4
$304K Buy
+65,315
New +$359K ﹤0.01% 2976

Other funds holding GDRX

IMC Chicago's GDRX Position: Q2 2026 in Review

IMC Chicago reduced its GoodRx Holdings (GDRX) stake by 53% in Q2 2026, selling an estimated $106K and leaving 36,250 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #5970.

IMC Chicago first reported a position in GDRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $392K in Q2 2025. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • IMC Chicago held 36,250 shares of GoodRx Holdings worth $104K as of Q2 2026.
  • IMC Chicago sold 41,654 GoodRx Holdings shares in Q2 2026, an estimated $106K.
  • GoodRx Holdings made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #5970 holding.
  • IMC Chicago first reported a position in GoodRx Holdings in Q4 2024 and has held it in 7 quarters since.
  • IMC Chicago's GoodRx Holdings position peaked at $392K in Q2 2025.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.